公司概覽
業務類別 --
業務概覽 Founded in 2004 and listing on the Hong Kong Exchange in 2023, Adicon is one of the largest independent clinical laboratories in China. In October 2018, private equity Carlyle Group completed its investment in Adicon and has since been thelargest single shareholder. Following Carlyle's investment, Adicon quickly stepped up its footprint. It has a testing portfolio of over 4,000 medical diagnostic tests with 36 self-operated laboratories in 2023, compared with 1,800 items and 21 labs in 2018. Currently, esoteric tests account for nearly 60% of its testing portfolio. Esoteric tests require more specialized technologies and/or equipment.
公司地址 No. 208, Zhenzhong Road, West Lake, Zhejiang, Hangzhou, CHN
電話號碼 +86 57187779340
傳真號碼 --
公司網頁 https://www.adicon.com.cn
員工數量 5445
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Song Gao Director and Chief Executive Officer -- 24/04/2025
 
董事會成員
董事會 職務 更新日期
Mr. Song Gao Director and Chief Executive Officer 24/04/2025
Dr. Brian Zihou Mi, PhD Independent Director 24/04/2025
Ms. Janine Junyuan Feng Director 24/04/2025
Mr. Jixun Lin Director 24/04/2025
Ms. Ling Yang Chairwoman of the Board 24/04/2025
Mr. Richard Yeh Independent Director 24/04/2025
Dr. Wei Zhang, M.D.,PhD Independent Director 24/04/2025
Mr. Mintao Zhou Director 24/04/2025
 
所屬ETF (更新日期: 07/03/2026 02:11)
代號 名稱 佔比% 持有日期
VTVanguard Total World Stock ETF0.03%31/01/2026
EWXState Street® SPDR® S&P® EM Sm Cp ETF0.02%27/02/2026
DFEMDimensional Emerging Markets Cr Eq 2 ETF0.01%27/02/2026
VSGXVanguard ESG International Stock ETF0.01%31/01/2026
SPGMState Street® SPDR® Ptf MSCIGlbStkMktETF0.004%27/02/2026
DFAXDimensional World ex US Core Eq 2 ETF0.004%27/02/2026
DFAEDimensional Emerging Core Equity Mkt ETF0.003%27/02/2026
AVEEAvantis Emerging Markets Sm Cp Eq ETF0.002%28/02/2026
ECNSiShares MSCI China Small-Cap ETF<0.000001%28/02/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.